Bicara Therapeutics Inc. (BCAX)

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$17.62
Day's range
$19.75

Bicara Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 02/17/2026 6.96 M $117.07 M   0.00% 12.75%
SIREN, L.L.C. 02/13/2026 5.22 M $87.80 M   0.00% 9.56%
VESTAL POINT CAPITAL, LP 02/17/2026 3.58 M $60.17 M   -29.90% 6.55%
FMR LLC 02/17/2026 3.35 M $56.33 M   24.05% 6.13%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 02/19/2026 3.24 M $54.47 M   596.45% 5.93%
RED TREE MANAGEMENT, LLC 02/11/2026 3.17 M $53.36 M   0.00% 5.81%
TPG GP A, LLC 02/13/2026 3.01 M $50.67 M   0.00% 5.52%
JANUS HENDERSON GROUP PLC 02/17/2026 2.65 M $44.48 M   100.00% 4.85%
DEEP TRACK CAPITAL, LP 02/13/2026 2.61 M $43.99 M   7.72% 4.79%
BLACKROCK, INC. 02/12/2026 2.53 M $42.55 M   9.37% 4.63%
OMEGA FUND MANAGEMENT, LLC 02/17/2026 2.20 M $37.10 M   0.00% 4.04%
VANGUARD GROUP INC 01/29/2026 2.19 M $36.79 M   -0.67% 4.01%
STATE STREET CORP 02/13/2026 1.65 M $27.76 M   179.45% 3.02%
FRANKLIN RESOURCES INC 02/11/2026 1.62 M $27.27 M   100.00% 2.97%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 1.56 M $26.25 M   -11.16% 2.86%
04/01/2026 1.26 M $45.86 M   100.00% 2.32%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 811.40 K $13.66 M   -2.38% 1.49%
CITADEL ADVISORS LLC 02/17/2026 772.26 K $13.00 M   100.00% 1.42%
FIL LTD 02/17/2026 758.49 K $12.77 M   -5.63% 1.39%
ACORN CAPITAL ADVISORS, LLC 02/17/2026 643.38 K $10.83 M   0.00% 1.18%
AISLING CAPITAL MANAGEMENT LP 02/10/2026 568.92 K $9.57 M   0.00% 1.04%
GOLDMAN SACHS GROUP INC 03/25/2026 552.33 K $9.30 M   137.30% 1.01%
MILLENNIUM MANAGEMENT LLC 02/17/2026 434.70 K $7.32 M   -57.17% 0.80%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/17/2026 429.10 K $7.22 M   15.76% 0.79%
ENSIGN PEAK ADVISORS, INC 02/12/2026 401.44 K $6.76 M   100.00% 0.74%
NAN FUNG TRINITY (HK) LTD 02/04/2026 372.39 K $6.27 M   -3.25% 0.68%
BANK OF AMERICA CORP /DE/ 02/17/2026 335.68 K $5.65 M   -26.49% 0.62%
ALGERT GLOBAL LLC 02/17/2026 318.27 K $5.36 M   1,709.37% 0.58%
CLEARBRIDGE INVESTMENTS, LLC 02/11/2026 298.76 K $5.03 M   -7.88% 0.55%
PALO ALTO INVESTORS LP 02/17/2026 298.58 K $5.03 M   100.00% 0.55%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 272.15 K $4.58 M   -3.11% 0.50%
DAFNA CAPITAL MANAGEMENT LLC 02/17/2026 261.58 K $4.40 M   -17.48% 0.48%
TD ASSET MANAGEMENT INC 02/10/2026 244.63 K $4.12 M   32.24% 0.45%
NORTHERN TRUST CORP 02/17/2026 237.11 K $3.99 M   -9.11% 0.43%
WOODLINE PARTNERS LP 02/17/2026 232.69 K $3.92 M   -33.27% 0.43%
ORBIMED ADVISORS LLC 02/17/2026 209.10 K $3.52 M   100.00% 0.38%
UBS GROUP AG 01/29/2026 192.19 K $3.23 M   97.40% 0.35%
HUDSON BAY CAPITAL MANAGEMENT LP 02/13/2026 150.00 K $2.52 M   100.00% 0.27%
D. E. SHAW & CO., INC. 02/17/2026 136.52 K $2.30 M   100.00% 0.25%
DEUTSCHE BANK AG\ 02/11/2026 128.63 K $2.16 M   0.92% 0.24%
NAPEAN TRADING & INVESTMENT CO (SINGAPORE) PTE LTD 02/13/2026 113.78 K $1.91 M   -58.77% 0.21%
HEALTHINVEST PARTNERS AB 02/06/2026 111.36 K $1.87 M   -45.34% 0.20%
MORGAN STANLEY 02/13/2026 109.46 K $1.84 M   9.43% 0.20%
BARCLAYS PLC 02/13/2026 103.24 K $1.74 M   114.42% 0.19%
SOLEUS CAPITAL MANAGEMENT, L.P. 02/12/2026 100.00 K $1.68 M   100.00% 0.18%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/13/2026 98.92 K $1.60 M   -21.99% 0.18%
TWO SIGMA INVESTMENTS, LP 02/17/2026 98.48 K $1.66 M   3.41% 0.18%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 95.90 K $1.61 M   162.63% 0.18%
BANK OF NEW YORK MELLON CORP 02/10/2026 88.68 K $1.49 M   4.90% 0.16%
JANE STREET GROUP, LLC 02/12/2026 85.58 K $1.44 M   100.00% 0.16%

Bicara Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 181 institutional investors and hedge funds held shares of Bicara Therapeutics Inc.. The most heavily invested institutionals were:

Red Tree Management, LLC: 3.17 M

HealthInvest Partners AB: 1.17 M

Aisling Capital Management LP: 568,919

NAN FUNG TRINITY (HK) Ltd: 427,885

TD ASSET MANAGEMENT INC: 269,718

Candriam S.C.A.: 238,822

106.95% of Bicara Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 59.32 M shares in the last 24 months. This purchase volume represents approximately $1.17 B in transactions.